OSR (NASDAQ:OSRH – Get Free Report) and FG Merger II (NASDAQ:FGMC – Get Free Report) are both small-cap manufacturing companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.
Insider & Institutional Ownership
55.3% of OSR shares are held by institutional investors. 36.8% of OSR shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Volatility and Risk
OSR has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, FG Merger II has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| OSR | 1 | 0 | 0 | 0 | 1.00 |
| FG Merger II | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares OSR and FG Merger II’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| OSR | -363.26% | -7.24% | -5.41% |
| FG Merger II | N/A | 597.61% | 1.69% |
Valuation & Earnings
This table compares OSR and FG Merger II”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| OSR | $2.91 million | 4.86 | -$27.06 million | ($0.33) | -1.22 |
| FG Merger II | N/A | N/A | $1.43 million | $0.01 | 1,053.00 |
FG Merger II has lower revenue, but higher earnings than OSR. OSR is trading at a lower price-to-earnings ratio than FG Merger II, indicating that it is currently the more affordable of the two stocks.
Summary
FG Merger II beats OSR on 6 of the 10 factors compared between the two stocks.
About OSR
OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.
About FG Merger II
FG Merger II Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 20, 2023 and is headquartered in Itasca, IL.
Receive News & Ratings for OSR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OSR and related companies with MarketBeat.com's FREE daily email newsletter.
